Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04093596
Title Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) (UNIVERSAL)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Allogene Therapeutics
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope Duarte California 91010 United States Details
Stanford Cancer Institute Palo Alto California 94305 United States Details
Sarah Cannon/Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37203 United States Details
St. David's South Austin Medical Center Austin Texas 78704 United States Details
Texas Transplant Institute San Antonio Texas 78229 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field